| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 58 |
| 1 | MELPHALAN HYDROCHLORIDE | 40 |
| 2 | MELPHALAN | 33 |
| 3 | BEVACIZUMAB | 26 |
| 4 | AFLIBERCEPT | 25 |
| 5 | CARBOPLATIN | 21 |
| 6 | PENTOSAN POLYSULFATE SODIUM | 21 |
| 7 | HYDROXYCHLOROQUINE | 17 |
| 8 | VERTEPORFIN FOR INJECTION | 15 |
| 9 | TOPOTECAN | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VORETIGENE NEPARVOVEC-RZYL | 8 | 0.0526 |
| 1 | VERTEPORFIN FOR INJECTION | 15 | 0.0101 |
| 2 | INDOCYANINE GREEN | 1 | 0.0083 |
| 3 | TROPICAMIDE | 5 | 0.0031 |
| 4 | PENTOSAN POLYSULFATE SODIUM | 21 | 0.0030 |
| 5 | TETRACAINE | 1 | 0.0025 |
| 6 | RANIBIZUMAB | 58 | 0.0022 |
| 7 | TOPOTECAN | 13 | 0.0021 |
| 8 | BALSALAZIDE DISODIUM | 1 | 0.0019 |
| 9 | TEBENTAFUSP | 1 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 81 |
| 1 | Corticosteroid [EPC] | 28 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 3 | Platinum-based Drug [EPC] | 23 |
| 4 | Topoisomerase Inhibitor [EPC] | 21 |
| 5 | Photoenhancer [EPC] | 15 |
| 6 | Benzodiazepine [EPC] | 14 |
| 7 | Cholinergic Muscarinic Antagonist [EPC] | 13 |
| 8 | Thiazide Diuretic [EPC] | 11 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoenhancer [EPC] | 15 | 0.0039 |
| 1 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 2 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 3 | Antiseptic [EPC] | 3 | 0.0007 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 5 | 0.0006 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 10 | 0.0005 |
| 6 | Anticholinergic [EPC] | 8 | 0.0005 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 81 | 0.0004 |
| 8 | Cholinergic Muscarinic Antagonist [EPC] | 13 | 0.0003 |
| 9 | Topoisomerase Inhibitor [EPC] | 21 | 0.0003 |